| Purpose | Announcement Date | Meeting Date |
|---|---|---|
| EGM | 4 Dec 2023 | 4 Jan 2024 |
| Board Meeting held on December 04, 2023 has, inter-alia, considered and approved the proposal for fund raising upto to an amount of Rs. 4,20,00,000 by way on preferential basis through private placement Pursuant to Regulation 30 of SEBI(LODR) Regulation 2015, Please find enclosed Notice of an Extra-Ordinary General Meeting (EGM) of the Company Scheduled to be held on Thursday, January 04, 2024 at 2.30 p.m. (As Per BSE Announcement Dated on 12.12.2023) Proceedings of Extra-Ordinary General Meeting (EGM) of Ganga Pharmaceuticals Limited held on Thursday, January 04, 2024 Voting Result of the EGM of Ganga Pharmaceuticals Limited held on Thursday, January 04, 2024 along with Scrutinizers Report. (As per BSE Announcement Dated on 04/01/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
